An updated patent review on P-glycoprotein inhibitors (2011-2018). (3rd June 2019)
- Record Type:
- Journal Article
- Title:
- An updated patent review on P-glycoprotein inhibitors (2011-2018). (3rd June 2019)
- Main Title:
- An updated patent review on P-glycoprotein inhibitors (2011-2018)
- Authors:
- Leopoldo, Marcello
Nardulli, Patrizia
Contino, Marialessandra
Leonetti, Francesco
Luurtsema, Gert
Colabufo, Nicola Antonio - Abstract:
- ABSTRACT: Introduction : P-glycoprotein is a complex ATP-ase transporter involved in physiological and pathological functions. In particular, it is involved in the onset of multidrug resistance in cancer, in ocular disease, Chronic Rhinosinusitis, CNS diseases such as Alzheimer, Parkinson, and epilepsy. One of the aims of clinicians and pharmacologists is to monitor P-gp activity through the inhibitors and to use its activity and/or expression in physiological barriers for the early diagnosis of several pathologies. Considering P-glycoprotein activity, several substrates have been characterized but the challenge is to design ' pure ' P-glycoprotein inhibitors. Area covered : P-glycoprotein inhibitors display a large spectrum of activities. Here the contents of patents focused on the role of P-glycoprotein inhibitor in modulating MDR in cancer, in bioavailability, in ocular disease and Chronic Rhinosinusitis are reported. Expert opinion : the use of P-glycoprotein inhibitor sic et simpliciter, or in coadministration with therapeutic agents, for ocular disease, and Chronic Rhinosinusitis is promising and could be suggested for additional trials. By contrast, the bioavailability of the coadministrated drugs, increased by P-glycoprotein inhibitor, deserves a wider discussion, in particular on the pharmacokinetic aspect of both P-glycoprotein inhibitor and the coadministered drug.
- Is Part Of:
- Expert opinion on therapeutic patents. Volume 29:Number 6(2019)
- Journal:
- Expert opinion on therapeutic patents
- Issue:
- Volume 29:Number 6(2019)
- Issue Display:
- Volume 29, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 6
- Issue Sort Value:
- 2019-0029-0006-0000
- Page Start:
- 455
- Page End:
- 461
- Publication Date:
- 2019-06-03
- Subjects:
- P-glycoprotein inhibitors -- multidrug resistance -- ocular disease -- Chronic Rhinosinusitis -- bioavailability
Drugs -- Patents -- Periodicals
615.10272 - Journal URLs:
- http://www.tandfonline.com/toc/ietp20/current ↗
http://informahealthcare.com/journal/etp ↗
http://informahealthcare.com ↗
http://juno.ashley-pub.com/vl=452196/cl=85/nw=1/rpsv/journal/journal7_home.htm ↗ - DOI:
- 10.1080/13543776.2019.1618273 ↗
- Languages:
- English
- ISSNs:
- 1354-3776
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002960
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17272.xml